Congress passes coronavirus relief bill, slating $4.3B for CDC, $3.5B for BARDA, $945M for NIH, $80M for FDA

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The House of Representatives March 27 passed a $2 trillion coronavirus relief package to “prevent, prepare for, and respond to coronavirus, domestically or internationally.” The bill appropriates pandemic response funds in the following amounts: $4.3 billion for CDC, $945.4 million for NIH, $80 million for FDA, and $200 million for CMS.

The Senate voted to approve the legislation 96-0 on March 25. President Donald Trump is expected to sign the bill immediately. The Coronavirus Aid, Relief and Economic Security (CARES) Act is the largest economic stimulus measure to date in U.S. history.

The bill provides $3.5 billion to the Biomedical Advanced Research and Development Authority “for necessary expenses of manufacturing, production, and purchase … of vaccines, therapeutics, diagnostics, and small molecule active pharmaceutical ingredients, including the development, translation, and demonstration at scale of innovations in manufacturing platforms.”

Here’s a breakdown of the allocations by agency, institute, and program:


Centers for Disease Control and Prevention: $4.3 billion

  • $1.5 billion for states etc. to “carry out surveillance, epidemiology, laboratory capacity, infection control, mitigation, communications, and other preparedness and response activities”

  • $500 million for “global disease detection and emergency response”

  • $500 million for “public health data surveillance and analytics infrastructure modernization”

  • $300 million for the Infectious Disease Rapid Response Reserve Fund


National Institutes of Health: $945.4 million

  • National Institute of Allergy and Infectious Diseases: $706 million, of which $156 million is allocated for “vaccine and infectious diseases research”

  • National Heart, Lung, and Blood Institute: $103.4 million

  • National Institute of Biomedical Imaging and Bioengineering: $60 million

  • National Center for Advancing Translational Sciences: $36 million

  • Office of the Director: $30 million

  • National Library of Medicine: $10 million


Food and Drug Administration: $80 million

  • Salaries and Expenses: $80 million, including funds “for the development of necessary medical countermeasures and vaccines, advanced manufacturing for medical products, the monitoring of medical product supply chains, and related administrative activities.”


Centers for Medicare and Medicaid Services: $200 million

  • Program Management: $200 million, of which $100 million is allocated for the survey and certification program and prioritizing nursing home facilities in localities with community transmission of coronavirus


Substance Abuse and Mental Health Services Administration: $425 million

  • Health Surveillance and Program Support: $425 million

Table of Contents

YOU MAY BE INTERESTED IN

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.

Login